In human DCs, endothelial cells (ECs), and tumor cell lines, ICOSL signaling inhibits adhesiveness and migration; in human DCs, it also modulates cytokine secretion and promotes antigen cross-presentation, whereas in osteoclasts it hampers bone homeostasis. Here, ICOSLG is linked to neoplasm.